News and Announcements
Universal Biosensors Q3 2015 Results, Investor Presentation and CEO Audio Interview
- Published October 30, 2015 12:16PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
29th October 2015, ASX Announcement
- Total revenue up 187% on pcp to $6.0m
- Quarterly Service Fees up 113% on pcp to $3.4m
- Coagulation strip manufacturing revenue up 303% on pcp to $553k
- Net R&D costs (including accrued R&D tax rebate) of $2.6m
- Net loss of 163k (down from $1.9m on pcp)
- Cash balance as at 30 September 2015 of $17.4m
To read the full announcement, please click here.
To view the Investor Presentation, please click here.
To listen to the CEO Interview, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
